BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20351234)

  • 1. Overexpression of urokinase by plaque macrophages causes histological features of plaque rupture and increases vascular matrix metalloproteinase activity in aged apolipoprotein e-null mice.
    Hu JH; Du L; Chu T; Otsuka G; Dronadula N; Jaffe M; Gill SE; Parks WC; Dichek DA
    Circulation; 2010 Apr; 121(14):1637-44. PubMed ID: 20351234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Level of macrophage uPA expression is an important determinant of atherosclerotic lesion growth in Apoe-/- mice.
    Krishnan R; Kremen M; Hu JH; Emery I; Farris SD; Slezicki KI; Chu T; Du L; Dichek HL; Dichek DA
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1737-44. PubMed ID: 19729604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallel Murine and Human Plaque Proteomics Reveals Pathways of Plaque Rupture.
    Vaisar T; Hu JH; Airhart N; Fox K; Heinecke J; Nicosia RF; Kohler T; Potter ZE; Simon GM; Dix MM; Cravatt BF; Gharib SA; Dichek DA
    Circ Res; 2020 Sep; 127(8):997-1022. PubMed ID: 32762496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of mouse atherosclerosis by urokinase inhibition or with a limited-spectrum matrix metalloproteinase inhibitor.
    Hu JH; Touch P; Zhang J; Wei H; Liu S; Lund IK; Høyer-Hansen G; Dichek DA
    Cardiovasc Res; 2015 Mar; 105(3):372-82. PubMed ID: 25616415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice.
    Moriwaki H; Stempien-Otero A; Kremen M; Cozen AE; Dichek DA
    Circ Res; 2004 Sep; 95(6):637-44. PubMed ID: 15297377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of urokinase plasminogen activator promotes progression and instability of atherosclerotic lesions in apolipoprotein E-knockout mice.
    Dellas C; Schremmer C; Hasenfuss G; Konstantinides SV; Schäfer K
    Thromb Haemost; 2007 Jul; 98(1):220-7. PubMed ID: 17598016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteins.
    Farris SD; Hu JH; Krishnan R; Emery I; Chu T; Du L; Kremen M; Dichek HL; Gold E; Ramsey SA; Dichek DA
    J Biol Chem; 2011 Jun; 286(25):22665-77. PubMed ID: 21536666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen mediates the atherogenic effects of macrophage-expressed urokinase and accelerates atherosclerosis in apoE-knockout mice.
    Kremen M; Krishnan R; Emery I; Hu JH; Slezicki KI; Wu A; Qian K; Du L; Plawman A; Stempien-Otero A; Dichek DA
    Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17109-14. PubMed ID: 18957535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibronectin Containing Extra Domain A Induces Plaque Destabilization in the Innominate Artery of Aged Apolipoprotein E-Deficient Mice.
    Doddapattar P; Jain M; Dhanesha N; Lentz SR; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):500-508. PubMed ID: 29326316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-targeted overexpression of urokinase causes accelerated atherosclerosis, coronary artery occlusions, and premature death.
    Cozen AE; Moriwaki H; Kremen M; DeYoung MB; Dichek HL; Slezicki KI; Young SG; Véniant M; Dichek DA
    Circulation; 2004 May; 109(17):2129-35. PubMed ID: 15096455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
    Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase-type plasminogen activator deficiency in bone marrow-derived cells augments rupture of angiotensin II-induced abdominal aortic aneurysms.
    Uchida HA; Poduri A; Subramanian V; Cassis LA; Daugherty A
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2845-52. PubMed ID: 21868698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of cardiac fibrosis induced by urokinase plasminogen activator.
    Stempien-Otero A; Plawman A; Meznarich J; Dyamenahalli T; Otsuka G; Dichek DA
    J Biol Chem; 2006 Jun; 281(22):15345-51. PubMed ID: 16554301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice.
    Gough PJ; Gomez IG; Wille PT; Raines EW
    J Clin Invest; 2006 Jan; 116(1):59-69. PubMed ID: 16374516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plaque Size Is Decreased but M1 Macrophage Polarization and Rupture Related Metalloproteinase Expression Are Maintained after Deleting T-Bet in ApoE Null Mice.
    Tsaousi A; Hayes EM; Di Gregoli K; Bond AR; Bevan L; Thomas AC; Newby AC
    PLoS One; 2016; 11(2):e0148873. PubMed ID: 26886778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells.
    Singh I; Burnand KG; Collins M; Luttun A; Collen D; Boelhouwer B; Smith A
    Circulation; 2003 Feb; 107(6):869-75. PubMed ID: 12591758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of laminin in matrix induction of macrophage urokinase-type plasminogen activator and 92-kDa metalloproteinase expression.
    Khan KM; Falcone DJ
    J Biol Chem; 1997 Mar; 272(13):8270-5. PubMed ID: 9079647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between atherosclerotic plaque characteristics and extracellular matrix metalloproteinase inducer and urokinase-type plasminogen activator in patients with coronary artery disease].
    Yang L; Tian X; Guo R; Liu H; Qi F; Ye J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Sep; 42(9):740-3. PubMed ID: 25511093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm.
    Deng GG; Martin-McNulty B; Sukovich DA; Freay A; Halks-Miller M; Thinnes T; Loskutoff DJ; Carmeliet P; Dole WP; Wang YX
    Circ Res; 2003 Mar; 92(5):510-7. PubMed ID: 12600880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta differently regulates urokinase type plasminogen activator and matrix metalloproteinase-9 expression in mouse macrophages; analysis of intracellular signal transduction.
    Mojsilović SS; Santibanez JF
    Cell Biol Int; 2015 May; 39(5):619-28. PubMed ID: 25597879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.